Objective: To study the feasibility of the acute gastrointestinal injury (AGI) classification standard for evaluation of gastrointestinal function in intensive care unit (ICU) patients, and to discuss its value in administration of early enteral nutrition (EN).
Methods: A perspective study was conducted. 85 patients with AGI admitted to ICU of Tianjin First Center Hospital from January 2013 to June 2013 were enrolled. EN was conducted after ICU admission or within 12-24 hours after high catabolic state. The patients were divided into four groups according to the AGI classification, i.e. grade I, II, III, and IV, and they were treated according to the treatment procedure for AGI. The primary end points were 7-day rate of intake of standard EN, the degree of disease and nutrition, and their correlation with AGI classification. Secondary endpoint was rate of giving EN within 48 hours.
Results: Gastrointestinal dysfunction patients accounted for 49.42% (85/172) of the ICU patients, and number of patients in grade I, II, III, IV were 29, 28, 19, 9 respectively. On the first day of ICU stay, there were no statistical differences in age, acute physiology and chronic health evaluation II (APACHEII) score, serum albumin (ALB) and prealbumin (PA) among four groups, and it was demonstrated that the baseline data were comparable. APACHEII score on the seventh day of ICU stay was significantly lower than that on the first day in grade I, II and III patients (grade I: 20.48±2.45 vs. 22.59±2.06, t=-3.120, P=0.031; grade II: 19.34±1.80 vs. 21.65±2.22, t=-4.316, P=0.012; grade III: 20.63±1.34 vs. 23.31±1.70, t=-5.640, P=0.000), and serum PA was significantly increased (grade I: 24.37±6.54 g/L vs. 10.62±7.24 g/L, t=-4.866, P=0.000; grade II: 19.79±12.48 g/L vs. 11.57±8.94 g/L, t=-2.116, P=0.031; grade III: 19.15±8.43 g/L vs. 13.78±6.59 g/L, t=-3.601, P=0.000). On the seventh day of ICU stay, the APACHEII score was higher in grade IV than that in grade I, II and III patients (22.87±3.31 vs. 20.48±2.45, 19.34±1.80, 20.63±1.34, P<0.05 or P<0.01), and PA was obviously lower in grade IV than that in grade I, II and III patients (14.02±8.70 g/L vs. 24.37±6.54 g/L, 19.79±12.48 g/L, 19.15±8.43 g/L, P<0.05 or P<0.01). There was no statistically significant difference among four groups in respect of serum ALB (F=0.454, P=0.722). The rate of giving EN in 24 hours in grade I, II, III, IV patients was 95.4%, 72.1%, 52.0% and 0, respectively (χ2=8.310, P=0.016), and in 48 hours it was 100.0%, 83.0%, 76.0%, and 0 (χ2=5.470, P=0.025). 7-day standard EN intake rate was 100.0%, 88.7%, 84.0% and 34.0% respectively in grade I, II, III, IV patients (χ2=0.720, P=0.017). Correlation analysis showed that there was a negative correlation between AGI classification and rate of giving EN in 1 day (r=-0.62, P=0.04) and 7-day standard EN intake rate (r=-0.76, P=0.02).
Conclusions: AGI classification can be used to estimate the gastrointestinal function of patients with critical illness, and it has a significant correlation with early EN support. An early goal achieving intervention based on the AGI classification can improve the nutritional status and the general state of the patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3760/cma.j.issn.2095-4352.2014.04.003 | DOI Listing |
Blood
January 2025
Stanford University Medical Center, Stanford, California, United States.
Allogeneic hematopoietic cell transplantation (HCT) is a curative therapy limited by graft-versus-host disease (GVHD). In preclinical studies and early-phase clinical studies enrichment of donor regulatory T cells (Tregs) appears to prevent GVHD and promote healthy immunity.We enrolled 44 patients on an open-label, single-center, phase 2 efficacy study investigating if a precision selected and highly purified Treg cell therapy manufactured from donor mobilized peripheral blood improves one-year GVHD-free relapse free survival (GRFS) after myeloablative conditioning (trial NCT01660607).
View Article and Find Full Text PDFJ Cancer Res Ther
December 2024
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
Background: Patients with transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) have limited treatment options and poor outcomes.
Methods: This phase III study (NCT04236141) evaluated the efficacy and safety of polatuzumab vedotin plus bendamustine and rituximab (Pola+BR) versus BR in Chinese patients with transplant-ineligible R/R DLBCL to support regulatory submission in China. Patients were randomized 2:1 to receive Pola+BR or placebo+BR.
Eur Arch Otorhinolaryngol
January 2025
Department of Otolaryngology-Head and Neck Surgery, Temerty Faculty of Medicine, University of Toronto, 6 Queen's Park Crescent West, Suite 120, Toronto, ON, M5S 3H2, Canada.
Purpose: The SARS-CoV-2 vaccination has reduced COVID-19 infection, though facial nerve palsy (FNP) has emerged as a notable side effect of the vaccine. We evaluated the current literature on the clinical presentation and outcomes of FNP related to COVID-19 vaccination.
Methods: A comprehensive search of seven databases was conducted for studies up to January 2023.
Investig Clin Urol
January 2025
Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Purpose: To evaluate the feasibility of robot-assisted ureteral reconstruction as a minimally invasive alternative to open surgery for managing ureteric complications in transplanted kidneys.
Materials And Methods: From January 2020 to December 2023, robot-assisted ureteral reconstruction was performed on fifteen kidney transplant patients with vesicoureteral reflux (VUR) or ureteral stricture who had previously failed endoscopic treatments.
Results: Twelve females and three males, with a mean age of 48.
Cureus
December 2024
Department of Cardiovascular Medicine, Khyber Medical Institute of Medical Sciences, Kohat, PAK.
Background: Percutaneous nephrolithotomy (PCNL) is the preferred treatment for large renal stones, yet variability in outcomes arises from patient-specific factors and institutional practices. Understanding complications and predictors of success is essential to improving procedural efficacy.
Objective: This study aimed to evaluate stone clearance rates, complications classified using the Clavien-Dindo system, and predictors of PCNL outcomes, with a focus on improving lower calyx stone clearance.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!